ResearcherUniversity of FlorenceActive in the last 2 years
Claudia Duranti
Matched on ORCID iD 0000-0002-0409-0037; OpenAlex author ID A5006863555. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper
Papers 5
- Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. Co-author DOI 10.1038/s41420-025-02321-2↗
- Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Ductal Adenocarcinoma. First author DOI 10.3390/cancers15072013↗
- Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection. Co-author DOI 10.3791/63123↗
- Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreatic Cancer and Stellate Cells. Co-author DOI 10.3390/cancers12030640↗
- The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.3390/cancers11020135↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Annarosa Arcangeli · 5 shared papers, 2019–2025 · strength 0.76
- Paper Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. DOI 10.1038/s41420-025-02321-2↗
- Paper Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection. DOI 10.3791/63123↗
- Paper Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Du… DOI 10.3390/cancers15072013↗
- Tiziano Lottini · 3 shared papers, 2021–2025 · strength 0.56
- Paper Targeting the hERG1/β1 integrin complex in lipid rafts potentiates statins anti-cancer activity in pancreatic cancer. DOI 10.1038/s41420-025-02321-2↗
- Paper Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection. DOI 10.3791/63123↗
- Paper Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Du… DOI 10.3390/cancers15072013↗
- Stefano Coppola · 2 shared papers, 2019–2023 · strength 0.25
- Paper Combination Therapy with a Bispecific Antibody Targeting the hERG1/β1 Integrin Complex and Gemcitabine in Pancreatic Du… DOI 10.3390/cancers15072013↗
- Paper The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Ade… DOI 10.3390/cancers11020135↗
- Lara Magni · 2 shared papers, 2019–2020 · strength 0.20
- Paper Proton Pump Inhibitors Reduce Pancreatic Adenocarcinoma Progression by Selectively Targeting H+, K+-ATPases in Pancreat… DOI 10.3390/cancers12030640↗
- Paper The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Ade… DOI 10.3390/cancers11020135↗
- Elena Lastraioli · 1 shared paper, 2023 · strength 0.16
- Alessandro Coppola · 1 shared paper, 2023 · strength 0.16
- Vincenzo La Vaccara · 1 shared paper, 2023 · strength 0.16
- Roberto Coppola · 1 shared paper, 2023 · strength 0.16
- Marco Tozzi · 1 shared paper, 2020 · strength 0.11
- Ivana Novak · 1 shared paper, 2020 · strength 0.11
- Sagar S. Manoli · 1 shared paper, 2019 · strength 0.09
- Thomas Schmidt · 1 shared paper, 2019 · strength 0.09
- Albrecht Schwab · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.